WINNIPEG, Manitoba, Oct. 19, 2020 (GLOBE NEWSWIRE) — DELTA 9 CANNABIS INC. (TSX: DN) (OTCQX: VRNDF) (“Delta 9” or the “Company”) is pleased to announce that it has entered into an asset purchase agreement (the “Purchase Agreement”) to acquire from Auxly Cannabis Group Inc. and Kolab Project Inc. (collectively the “Vendors”) all or substantially allContinue reading “Delta 9 Enters Into Agreement to Acquire Saskatchewan Retail Cannabis Store”
Tag Archives: investing in Auxly
Auxly’s Subsidiary KGK Science Receives Research Licence to Conduct Product Palatability and Sensory Testing with Human Subjects
— Auxly Cannabis Group Inc. (TSX.V – XLY) (“Auxly” or the “Company”), a consumer packaged goods company in the cannabis products market, is thrilled to announce that its wholly owned subsidiary, KGK Science Inc. (“KGK”) has received its second Cannabis Research Licence from Health Canada pursuant to the Cannabis Act. This licence permits KGK to administer cannabis extracts, edibleContinue reading “Auxly’s Subsidiary KGK Science Receives Research Licence to Conduct Product Palatability and Sensory Testing with Human Subjects”
Auxly Files Early Warning Report
— Auxly Cannabis Group Inc. (TSX.V – XLY) (“Auxly” or the “Company“) announces pursuant to the requirements of National Instrument 62-103 – The Early Warning System and Related Take-Over Bid and Insider Reporting Issues and applicable Canadian securities legislation that on September 17, 2020, the Company completed a disposition of 6,000,000 common shares and $400,000 worth of convertible debenturesContinue reading “Auxly Files Early Warning Report”
Auxly Closes $2 Million Tranche of Financing
— Auxly Cannabis Group Inc. (TSX.V: XLY) (OTCQX: CBWTF) (“Auxly” or the “Company”) has issued an additional $2 million worth of unsecured convertible debentures (the “Tranche”) under its $25 million unsecured convertible debenture standby facility with an institutional investor (the “Investor”) as previously announced on April 28, 2020 (the “Original Offering”). Under the Tranche, the convertible debenturesContinue reading “Auxly Closes $2 Million Tranche of Financing”
Auxly Reports Q2 2020 Financial Results
— Auxly Cannabis Group Inc. (TSX.V – XLY) (OTCQX: CBWTF) (“Auxly” or the “Company“) today released its financial results for the three and six months ended June 30, 2020. These filings and additional information regarding Auxly are available for review on SEDAR at http://www.sedar.com. All amounts are Canadian dollars except common shares (“Shares”) and per Share amounts.Continue reading “Auxly Reports Q2 2020 Financial Results”
Auxly’s Subsidiary Dosecann Receives Research Licence to Conduct Product Palatability and Sensory Testing with Human Subjects
— Auxly Cannabis Group Inc. (TSX.V – XLY) (“Auxly” or the “Company”), a consumer packaged goods company in the cannabis products market, is thrilled to announce that its wholly owned subsidiary, Dosecann LD Inc. (“Dosecann”) has received its Cannabis Research Licence from Health Canada pursuant to the Cannabis Act. This licence permits Dosecann to administer cannabis extracts, edible cannabisContinue reading “Auxly’s Subsidiary Dosecann Receives Research Licence to Conduct Product Palatability and Sensory Testing with Human Subjects”
Auxly Provides Update on Cultivation Strategy
— Auxly Cannabis Group Inc. (TSX.V – XLY) (“Auxly” or the “Company”), a consumer packaged goods company in the cannabis products market, today provided an update on the Company’s national and international cultivation strategy. The Company is pleased by the progress of its cultivation portfolio, which is instrumental in supplying a secure, cost-efficient and consistent source of inputContinue reading “Auxly Provides Update on Cultivation Strategy”
Auxly Announces Annual General and Special Meeting of Shareholders and COVID-19 Precautionary Guidance
— Auxly Cannabis Group Inc. (TSX.V – XLY) (OTCQX: CBWTF) (“Auxly” or the “Company“) announced today that it will hold its Annual General and Special Meeting of Shareholders (the “Meeting”) on Wednesday, July 15, 2020 at 2:00 p.m. EST at the offices of McCarthy Tétrault LLP, Suite 5300, TD Bank Tower, Toronto, Ontario M5K 1E6. COVID-19 GuidanceContinue reading “Auxly Announces Annual General and Special Meeting of Shareholders and COVID-19 Precautionary Guidance”
Auxly’s Subsidiary Dosecann Enters into Manufacturing and Distribution Agreement with dosist™, an Award-Winning Wellness Company
— Auxly Cannabis Group Inc. (TSX.V – XLY) (“Auxly” or the “Company”), a leading consumer packaged goods company in the derivative cannabis products market, is pleased to announce that its wholly-owned subsidiary Dosecann LD Inc. (“Dosecann”) has entered into an agreement with GSW Creative Corporation Canada Inc., doing business as dosist™ (“dosist”), to manufacture their proprietary wellnessContinue reading “Auxly’s Subsidiary Dosecann Enters into Manufacturing and Distribution Agreement with dosist™, an Award-Winning Wellness Company”
